Literature DB >> 16353248

Expression of prothymosin alpha is correlated with development and progression in human prostate cancers.

Shugo Suzuki1, Satoru Takahashi, Seishiro Takahashi, Kentaro Takeshita, Atsuya Hikosaka, Toshiaki Wakita, Naoki Nishiyama, Tamio Fujita, Takehiko Okamura, Tomoyuki Shirai.   

Abstract

BACKGROUND: Our previous study clearly demonstrated that decreased expression of prothymosin alpha (PTMA) was associated with inhibition of rat prostate carcinogenesis by isoflavones. The purpose of the present investigation was to provide a better understanding of the role of PTMA in human prostate cancers. METHODS AND
RESULTS: PTMA expression in 68 prostate cancer cases and in prostate cancer cell lines was examined by immunohistochemistry and immunoblotting, and its levels were increased with progression from normal epithelium, through prostatic intraepithelial neoplasia (PIN) to carcinomas, correlating with the Gleason's pattern. All cell lines studied (LNCaP, 22Rv1, DU145, and PC3) showed high PTMA expression compared with prostate epithelial cells (PrEC). Knockdown of PTMA expression in PC3 cells by RNAi resulted in the inhibition of both cell growth and invasion in vitro.
CONCLUSIONS: The present study clearly demonstrated that PTMA expression is intimately involved in the differentiation and progression of human prostate cancers, and could be a target for therapy and diagnostic purposes. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16353248     DOI: 10.1002/pros.20385

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  12 in total

1.  Prothymosin alpha is a component of a linker histone chaperone.

Authors:  Eric M George; David T Brown
Journal:  FEBS Lett       Date:  2010-04-29       Impact factor: 4.124

2.  Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury.

Authors:  Kenta Torigoe; Yoko Obata; Miki Torigoe; Satoru Oka; Kazuo Yamamoto; Takehiko Koji; Hiroshi Ueda; Hiroshi Mukae; Tomoya Nishino
Journal:  Clin Exp Nephrol       Date:  2020-01-07       Impact factor: 2.801

3.  Transgenic expression of prothymosin alpha on zebrafish epidermal cells promotes proliferation and attenuates UVB-induced apoptosis.

Authors:  Chiung-Wen Pai; Yau-Hung Chen
Journal:  Transgenic Res       Date:  2009-12-11       Impact factor: 2.788

4.  Integrative mixture of experts to combine clinical factors and gene markers.

Authors:  Kim-Anh Lê Cao; Emmanuelle Meugnier; Geoffrey J McLachlan
Journal:  Bioinformatics       Date:  2010-03-11       Impact factor: 6.937

5.  Identification of candidate cancer genes involved in human retinoblastoma by data mining.

Authors:  Juhua Yang; Jian-Jun Zhao; Yihua Zhu; Wei Xiong; Jian-Yin Lin; Xu Ma
Journal:  Childs Nerv Syst       Date:  2008-03-19       Impact factor: 1.475

6.  A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

Authors:  R Stephanie Huang; Shiwei Duan; Wasim K Bleibel; Emily O Kistner; Wei Zhang; Tyson A Clark; Tina X Chen; Anthony C Schweitzer; John E Blume; Nancy J Cox; M Eileen Dolan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-30       Impact factor: 11.205

7.  Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody.

Authors:  Persefoni Klimentzou; Angeliki Drougou; Birgit Fehrenbacher; Martin Schaller; Wolfgang Voelter; Calypso Barbatis; Maria Paravatou-Petsotas; Evangelia Livaniou
Journal:  J Histochem Cytochem       Date:  2008-08-18       Impact factor: 2.479

8.  Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.

Authors:  Satyendra Chandra Tripathi; Ajay Matta; Jatinder Kaur; Jorg Grigull; Shyam Singh Chauhan; Alok Thakar; Nootan Kumar Shukla; Ritu Duggal; Ajoy Roy Choudhary; Siddhartha Dattagupta; Mehar Chand Sharma; Ranju Ralhan; K W Michael Siu
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

9.  Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis.

Authors:  Anurag Kumar; Vikas Kumar; Mohit Arora; Manish Kumar; Prajwal Ammalli; Bhaskar Thakur; Jitender Prasad; Sarita Kumari; Mehar Chand Sharma; Shashank Sharad Kale; Shyam S Chauhan
Journal:  Biosci Rep       Date:  2022-04-29       Impact factor: 3.976

10.  Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspective.

Authors:  Caroline Mwendwa Kijogi; Christopher Khayeka-Wandabwa; Keita Sasaki; Yoshimasa Tanaka; Hiroshi Kurosu; Hayato Matsunaga; Hiroshi Ueda
Journal:  BMC Physiol       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.